ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,000 | +40.0% | 39 | -2.5% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 40 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | -16.7% | 40 | -11.1% | 0.00% | -100.0% |
| Q4 2020 | $6,000 | -93.3% | 45 | -94.3% | 0.00% | -83.3% |
| Q3 2020 | $89,000 | -83.1% | 787 | -85.8% | 0.01% | -82.4% |
| Q2 2020 | $528,000 | +98.5% | 5,530 | +86.7% | 0.03% | +61.9% |
| Q1 2020 | $266,000 | +4333.3% | 2,962 | +2308.1% | 0.02% | – |
| Q1 2019 | $6,000 | -60.0% | 123 | -65.1% | 0.00% | -100.0% |
| Q4 2018 | $15,000 | +114.3% | 352 | +186.2% | 0.00% | 0.0% |
| Q3 2018 | $7,000 | -99.9% | 123 | -3.1% | 0.00% | 0.0% |
| Q2 2018 | $6,162,000 | +123140.0% | 127 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | -50.0% | 127 | -45.0% | 0.00% | -100.0% |
| Q4 2017 | $10,000 | +66.7% | 231 | +36.7% | 0.00% | 0.0% |
| Q3 2017 | $6,000 | -25.0% | 169 | -33.5% | 0.00% | 0.0% |
| Q2 2017 | $8,000 | +14.3% | 254 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $7,000 | +16.7% | 254 | +2.4% | 0.00% | 0.0% |
| Q4 2016 | $6,000 | – | 248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
| NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
| Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
| SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
| Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
| RA Capital Management | 318,565 | $11,529,000 | 1.19% |
| OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
| Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
| Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
| QVT Financial LP | 636,764 | $23,044,000 | 0.87% |